V

ViroGates A/S
CSE:VIRO

Watchlist Manager
ViroGates A/S
CSE:VIRO
Watchlist
Price: 11.9 DKK -1.65% Market Closed
Market Cap: 92.1m DKK
Have any thoughts about
ViroGates A/S?
Write Note

Gross Margin
ViroGates A/S

57.3%
Current
74%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
57.3%
=
Gross Profit
2.4m
/
Revenue
4.2m

Gross Margin Across Competitors

Country DK
Market Cap 92.1m DKK
Gross Margin
57%
Country US
Market Cap 199B USD
Gross Margin
56%
Country US
Market Cap 191.3B USD
Gross Margin
67%
Country US
Market Cap 141.3B USD
Gross Margin
64%
Country US
Market Cap 134.2B USD
Gross Margin
69%
Country IE
Market Cap 104.6B USD
Gross Margin
65%
Country US
Market Cap 65.6B USD
Gross Margin
45%
Country DE
Market Cap 58.1B EUR
Gross Margin
38%
Country US
Market Cap 44.5B USD
Gross Margin
79%
Country CN
Market Cap 311.1B CNY
Gross Margin
64%
Country US
Market Cap 36.1B USD
Gross Margin
41%
No Stocks Found

ViroGates A/S
Glance View

Market Cap
92.1m DKK
Industry
Health Care

ViroGates A/S develops and markets prognostic products for the healthcare sector. Its develops a product line suPARnostic, which measures the amount of amount of soluble urokinase Plasminogen Activator Receptor protein (suPAR) in human blood. The plasma level of suPAR reflects immune activation and is increased in such infectious diseases as HIV-1-infection, malaria, tuberculosis, Streptococcus pneumonia bacteraemia, sepsis, pneumococcal pneumonia and bacterial and viral CNS infection. Also, high suPAR levels are associated with increased inflammation, disease progression and risk of mortality. Thus, measuring suPAR levels serves as a marker to determine chances for survival upon hospital admission, as well as for monitoring for prevention of disease progression and earlier intervention time point. suPARnostic has two versions: Quantitative Point of Care Quick Triage test, which serves for patient triage in acute care, and Quantitative ELISA Assay that aims at clinical routine use.

VIRO Intrinsic Value
3.15 DKK
Overvaluation 73%
Intrinsic Value
Price
V

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
57.3%
=
Gross Profit
2.4m
/
Revenue
4.2m
What is the Gross Margin of ViroGates A/S?

Based on ViroGates A/S's most recent financial statements, the company has Gross Margin of 57.3%.